Impact factor (WEB OF SCIENCE - Clarivate)

2 year: 7.664 | 5 year: 7.127

ArticlesCOVID-19Ongoing Research Themes

Coronavirus pandemic in the Nordic countries: Health policy and economy trade-off

Furqan B Irfan1,2, Raoul Minetti3, Ben Telford4, Fahad S Ahmed5, Ayesha Y Syed6, Nick Hollon4, Seth C Brauman4, William Cunningham1, Mohamed E Awad4, Khaled J Saleh4, Akbar K Waljee7,8, Nele Brusselaers9,10

1 Institute of Global Health, Michigan State University, East Lansing, Michigan, USA
2 Department of Neurology and Ophthalmology, College of Osteopathic Medicine, Michigan State University, East Lansing, Michigan, USA
3 Department of Economics, Michigan State University, Marshall-Adams Hall, East Lansing, Michigan, USA
4 College of Osteopathic Medicine, Michigan State University, East Lansing, Michigan, USA
5 Department of Pathology, Wayne State University, Detroit, Michigan, USA
6 Ferncare Free Clinic, Ferndale, Michigan, USA
7 University of Michigan Medical School, Institute for Healthcare Policy and Innovation, Ann Arbor, Michigan, USA
8 University of Michigan Medical School, Department of Internal Medicine, Division of Gastroenterology and Hepatology, Ann Arbor, Michigan, USA
9 Centre for Translational Microbiome Research, Department of Microbiology, Tumour and Cell Biology, Karolinska Institutet, Stockholm, Sweden
10 Global Health Institute, Antwerp University, Antwerpen, Wilrijk, Belgium

DOI: 10.7189/jogh.12.05017




Countries making up the Nordic region – Denmark, Finland, Iceland, Norway, and Sweden – have minimal socioeconomic, cultural, and geographical differences between them, allowing for a fair comparative analysis of the health policy and economy trade-off in their national approaches towards mitigating the impact of the COVID-19 pandemic.


This study utilized publicly available COVID-19 data of the Nordic countries from January 2020 to January 3, 2021. COVID-19 epidemiology, public health and health policy, health system capacity, and macroeconomic data were analysed for each Nordic country. Joinpoint regression analysis was performed to identify changes in temporal trends using average monthly percent change (AMPC) and average weekly percent change (AWPC).


Sweden’s health policy, being by far the most relaxed response to COVID-19, was found to have the largest COVID-19 incidence and mortality, and the highest AWPC increases for both indicators (13.5, 95% CI = 5.6, 22.0, P < 0.001; 6.3, 95% CI = 3.5, 9.1, P < 0.001). Denmark had the highest number of COVID-19 tests per capita, consistent with their approach of increased testing as a preventive strategy for disease transmission. Iceland had the second-highest number of tests per capita due to their mass-testing, contact tracing, quarantine and isolation response. Only Norway had a significant increase in unemployment (AMPC = 2.8%, 95% CI = 0.7-4.9, P < 0.009) while the percentage change in real Gross Domestic Product (GDP) was insignificant for all countries.


There was no trade-off between public health policy and economy during the COVID-19 pandemic in the Nordic region. Sweden’s relaxed and delayed COVID-19 health policy response did not benefit the economy in the short term, while leading to disproportionate COVID-19 hospitalizations and mortality.

Print Friendly, PDF & Email

Various strategies for containing and mitigating the COVID-19 pandemic have been implemented worldwide. Public health and response measures or non-pharmaceutical interventions (NPIs) have been utilized to varying degrees to contain and/or mitigate the pandemic, including face masks and hand hygiene, social distancing, border closures, lockdowns and stay-at-home mandates, closure of non-essential businesses and educational institutions, ban on mass gatherings, quarantine and patient isolation, mass screenings, and contact tracing [1]. The combined effect of the pandemic and the NPIs has resulted in economic impacts and hardship, making countries balance between implementing the NPIs and protecting the economy and livelihood of their populations [2].

The Nordic countries have similar population density, climate and lifestyle, and are among the top twelve developed countries according to the Human Development Index of the United Nations. Around 27 million people live in the Nordic countries, with 38% living in Sweden (10.1 million), 20% in Norway (5.4 million), 21% in Denmark (5.8 million), 20% in Finland (5.5 million) and 1% in Iceland (0.36 million). The limited socioeconomic and cultural differences between and within these countries make them the ideal setting for comparing the effect of different strategies to tackle the COVID-19 pandemic.

In these countries, the first COVID-19 cases were confirmed by the end of January 2020, with the first confirmed deaths occurring between March 11 and 23. While the “Swedish strategy” relied on the citizens’ responsibility for social distancing, working from home, hand washing and limiting non-essential travel, Norway, Finland, and Denmark implemented strict mitigation strategies with the main stated purpose of protecting the elderly and not overwhelming the health care system. Iceland had adopted a strict “test, trace and isolate” approach early on from March 2020 onwards.

The aim of the study was to determine how the Nordic countries have balanced this trade-off between the restrictive COVID-19 health policy and response measures and their impact on the economy. The COVID-19 public health and response measures will be determined for each Nordic country and their effectiveness assessed by the epidemiology of COVID-19, public health and health care capacity, and the community response to the COVID-19 guidelines. The associated negative economic effects will be measured by comparing the macroeconomic indicators and trends for the Nordic region during the pandemic. The generalisability and application of the trade-off in the Nordic countries to comparable regions will provide evidence for better understanding and decision-making, thereby contributing to the science on how to save lives and support the economy during a pandemic.


This study utilized publicly available COVID-19 data of the Nordic countries from January 2020 to January 3, 2021. Epidemiological COVID-19 data (relative numbers adjusted for population size unless otherwise mentioned) including incidence, mortality and case-fatality rate (CFR) were analysed using data sourced from the World Health Organization (WHO) Coronavirus (COVID-19) Dashboard and the European Centre for Disease Prevention and Control [3,4]. The CFR was defined as the number of deaths per confirmed COVID-19 cases (deaths from COVID-19/confirmed COVID-19 cases).

Public health and health system capacity was assessed by COVID-19 testing, test positivity rate [5], hospitalizations, and intensive care unit (ICU) admissions [6]. The test positivity rate was defined as the percentage of all tests conducted with positive results for COVID-19 infection (100 × number of new confirmed cases/number of tests performed) [7].

We also evaluated the health policy measures in the Government Response Stringency Index, a composite measure rescaled to a value from 0 to 100 (100 = strictest response) based on indicators that included: school closures, workplace closures, cancellation of public events, restrictions on public gatherings, closures of public transport, stay-at-home requirements, public information campaigns, restrictions on internal movements, and international travel controls [8,9].

Quantitative data were collected to evaluate the population response to the government’s health policy measures. “Social Distancing” estimates based on change in mobility from anonymous cell phone data from the Institute for Health Metrics and Evaluation (IHME) were also examined [10]. “Mask Use” data defined as “the percentage of the population who say they always wear a mask in public,” was also obtained from IHME [10].

The data from macroeconomic indicators to evaluate the effect of COVID-19 pandemic and health policy control measures on the economy included “Economic growth, percent change in quarterly real GDP” and unemployment rate (monthly), both of which were sourced from Organization for Economic Co-operation and Development (OECD) and the data repository [11,12].

Statistical methods

Corrections for populations were performed using 2020 mid-year population for the Nordic countries and standardizing data per 100 000 persons. A descriptive analysis was performed to determine the impact of COVID-19 in the Nordic countries utilizing the following variables: number of new COVID-19 cases, (per 100 000 persons), number of deaths, (per 100 000 persons), case-fatality (in percentage), COVID-19 tests conducted (per 100 000 persons), test positivity (in percentage), COVID-19 hospitalization (per 100 000 persons), COVID-19 intensive care unit (ICU) admissions (per 100 000 population).

Joinpoint regression analysis was performed to identify changes of temporal trends of pandemic development and response indicators. Joinpoint allows for the identification of time points that are associated with statistically significant changes in trends using a Monte Carlo permutation method and calculates the monthly (MPC) and weekly percentage changes (WPC) (weighted least-squares method) for each key indicator. Additionally, the WPCs were weighted by length of interval and averaged to calculate the average weekly percent change (AWPC). The AWPC allows for the use of a single number to describe the average WPCs throughout the course of the year [13]. It is valid even if the joinpoint model indicates that there were changes in trends throughout the year [13]. Analyses were stratified by country and performed using the Joinpoint software (version A p-value of <0.05 was considered statistically significant.

We obtained AWPC and their 95% confidence intervals (CI) during the study period, across the Nordic countries for the epidemiological, public health and health system capacity, health policy measures, population response variables. For monthly unemployment rate (in percentage) we obtained average monthly percent change (AMPC). We obtained quarterly data for real GDP growth for which joinpoint regression analysis was not feasible. Instead, quarterly percentage change was calculated for real GDP growth.


The COVID-19 mitigation strategies utilized by the Nordic countries are summarized in Table 1. Between January 2020 and January 3, 2021, there were 715 609 COVID-19 cases and 12 315 deaths in the Nordic region (Table 2). Denmark, Finland, and Norway had an initial peak of COVID-19 cases and deaths in April 2020 and then another sustained surge of COVID-19 cases and deaths that started in September and peaked from November 2020 to January 2021. Iceland had the initial peak of COVID-19 cases in March and the second wave of COVID-19 cases peaked from September to October 2020, with COVID-19 mortality surge following the peak of cases by a month. Sweden’s initial surge of COVID-19 cases and deaths was from April to June 2020, with the second surge occurring from November 2020 to January 2021. The CFR of confirmed cases was highest for Sweden (2.2%) followed by Finland (1.5%) and lowest for Iceland (0.5%) among the Nordic countries.

Table 1.  COVID-19 health policy and response measures utilized by the Nordic countries during 2020

Table 2.  Population, economy and COVID-19 epidemiology indicators from January 2020 to January 3, 2021

The country with the highest number of COVID-19 tests per 100 000 persons was Denmark, followed by Iceland. Iceland started large-scale testing the earliest, in March 2020, with sustained effort throughout the study period; Denmark had a gradual increase in COVID-19 tests starting in April and peaking in December 2020; Norway and Finland ramped up testing in July 2020; Sweden was the last to have an increase in testing during September 2020 (Figure 1). The overall test positivity was highest for Sweden (9.9%) with comparable numbers for the remaining countries. Sweden had the highest hospitalizations and ICU admissions, followed by Denmark, with comparable numbers for Finland and Norway (Table 2).

Figure 1.  Incidence of COVID-19, deaths with COVID-19, number of COVID-19 tests, hospitalization with COVID-19, ICU hospitalizations with COVID-19, from January 2020 to January 3, 2020.

The joinpoint regression analysis for CFR was calculated and analysed from April through December 2020. Iceland was excluded from the CFR analysis due to only 29 deaths being reported throughout the year. Overall, the CFR showed a statistically significant decrease in all countries analysed between April and September 2020, with Denmark showing the greatest decrease (MPC = -51.71%, P < 0.05) (Figure 2). The overall joinpoint regression analysis of the epidemiology, public health and health system capacity indicators during the study period were reported in Figure 3 using their respective AWPC, its 95% CIs and p-values. Denmark, Finland, Norway, and Sweden saw significant increases in their new COVID-19 case AWPC, of which Sweden saw the largest average increase with an AWPC of 13.5% (95% CI = 5.6, 22.0, P < 0.001) (Figure 3). All countries showed positive COVID-19 mortality AWPC, with Denmark and Sweden’s being considered significant. Of the two countries, Sweden had the largest AWPC (AWPC = 6.3%, 95% CI = 3.5, 9.1, P < 0.001) (Figure 3). COVID-19 tests AWPC were significantly positive in all countries except Iceland. Denmark had the largest significant positive AWPC of COVID-19 tests administered (AWPC = 14.0%, 95% CI = 8.82, 19.5, P < 0.001) (Figure 3). Denmark, Finland and Sweden showed an increase in hospitalization; Finland (AWPC = 3.2%, 95% CI = 0.4, 6.2, P < 0.05) and Sweden’s (AWPC = 3.1%, 95% CI = 1.5, 4.7, P < 0.001) increases were significant and comparable. For ICU occupancy, only Norway showed a statistically significant decrease in AWPC (AWPC = -4.2%, 95% CI = -8.0, -0.3, P = 0.04). Decrease in percent mobility was analysed from March to the end of December 2020 for all countries. Each country saw a decrease in mobility; however, only Sweden’s was statistically significant (AWPC = 3.0%, 95% CI = 0.54, 5.43, P = 0.02). Mask usage was analysed from February to the end of December 2020 for all countries; all countries saw a significant increase in AWPCs, with Norway having the largest increase (AWPC = 24.9%, 95% CI = 22.7, 27.1, P < 0.05) (Figure 3).

Figure 2.  Average monthly percent changes in CFR per country.

Figure 3.  The average weekly percent change (AWPC) for all COVID-19 indicators except unemployment rate. Unemployment rate is displayed as average monthly percent change (AMPC).

Unemployment data was reported monthly for each country and analysed to determine the AMPC. However, only Norway had an overall significant unemployment AMPC over the study period (AMPC = 2.8%, 95% CI = 0.7, 4.9%, P < 0.009) (Figure 3). The percentage change of real GDP was analysed using a non-logarithmic joinpoint regression of quarterly data which yielded the regression slope of each country. The percentage change of real GDP Trends for all countries were determined to be nonsignificant.


To our knowledge, this is the first study of its kind that performed an overall comparative regional analysis on COVID-19 health policy measures, epidemiology indicators and health care utilization, and macroeconomic outcomes. All Nordic countries, except Sweden, implemented relatively strict measures such as lockdowns early in the pandemic, and invested in testing, tracing, quarantine, and other protective measures to limit importing infections and spread within the country (Table 1). Sweden’s health policy did not include lockdowns, border controls or quarantine; there were no mandatory restriction measures to limit the number of people in public places, and until early December 2020, Sweden did not recommend face mask usage in public [14]. In contrast, Norway, Denmark, and Finland had strict measures with lockdowns, border controls and quarantine, as early as March 2020 [1517]. Iceland did not have a lockdown, but instead relied on an aggressive strategy of mass-testing, contact tracing, quarantine, and isolation [18] Denmark’s response was to “Act fast and act with force”; mitigation measures were implemented, and testing capacity was increased nationwide as a preventive strategy to decrease transmission [19,20]. This was also shown by Government Response Stringency Index (Figure 4) that had Norway, Denmark, Iceland, and Finland implement a strong initial response in March which was further strengthened in April and decreased gradually in response to decreasing test positivity (Figure 5). Sweden had a near static (WPC = -0.7, P < 0.05) response from April to mid-October 2020, despite large fluctuations in test positivity (Figure 4).

Figure 4.  Average weekly percent change (AWPC) in Government Response Stringency Index per country.

Figure 5.  Average weekly percent changes in Test Positivity per country.

Among all Nordic countries, the number of cases and mortality per capita, as well the number of hospitalizations and ICU admissions were highest in Sweden. Case fatality was 0.9% on average (0.5%-5%) for the other Nordic countries, and 2.2% for Sweden. The test positivity ratio was around 10% for Sweden, and below 2% in all other Nordic countries (in line with other reports), also indicating restricted testing in Sweden and probably the largest proportion of un-diagnosed cases in the Nordic region [20]. These results are similar to other COVID-19 studies in Nordic countries, including a comparative analysis of epidemiological indicators that included Sweden, Norway, Denmark, and Finland [20]. The highest number of COVID-19 tests was carried out in Denmark and Iceland, which correlated with their COVID-19 mitigation strategies. A recent study reported that Denmark had the highest number of COVID-19 tests – 3-4 times higher than its neighbours, which aligns to the findings in this study [20]. All countries had a significant AWPC increase in testing, except Iceland, which implemented a mass-testing strategy from the beginning. The AWPC increases in hospitalizations were comparable for Finland and Sweden, although total hospitalizations for Sweden (3191 per 100 000) were much higher than Finland (414 per 100 000). Only Norway had a significant decline in ICU hospitalizations (AWPC = -4.2%; 95% CI = -8.0, -2.9, P = 0.04). This is comparable to a recent study that showed Sweden had the highest number of ICU hospitalizations [17]. Existing health system capacity was critical: pre-pandemic Sweden had the lowest number of ICU beds per capita that were all occupied by April 25, 2020, and ICU beds were rapidly scaled while health systems across the country were being overwhelmed [20]. The community response showed a significant increase in the percentage of population with mask usage across all countries, with Sweden having the lowest average AWPC increase (AWPC = 11.7%, 95% CI = 10.9, 12.5, P < 0.001). Interestingly, while mask usage was the lowest, the Swedish population was the only one to exhibit an overall significant decrease in mobility [21,22]. All Nordic countries demonstrated an overall gradually declining mobility trend over the first 27 weeks (except for Finland) that was followed by a variable return to the baseline similar to other reports. The initial decline followed by an increase in mobility had the net effect of cancelling each other out, giving us the minimal non-significant changes in mobility. Sweden’s initial decline was approximately half of what we saw in the other Nordic countries which accounted for significant results.

From the macroeconomic perspective, the results do not reveal clear-cut benefits of the looser health policies adopted in Sweden when compared to the rest of the Nordic countries. For example, the trend in percentage change of real GDP was statistically insignificant for all Nordic countries. Compared with its Finnish and Danish neighbours, Sweden exhibits similar dynamics of the unemployment rate. Among these countries, only Norway (AMPC = 2.8%, 95% CI = 0.7, 4.9%, P < 0.009) performed significantly worse than Sweden in terms of unemployment. The similar macroeconomic performance of Sweden compared to other Nordic countries suggests that more stringent pandemic mitigation policies and containment can entail limited macroeconomic costs in the short run while enabling the aggregate economy to recover faster from a pandemic. Put differently, the results suggest that there is no trade-off between the restrictive COVID-19 policies to contain the COVID-19 pandemic and macroeconomic outcomes in the Nordic countries.

The economic profiles of the Nordic countries are similar: they are all open economies dependent on international trade [23]. We thus expect similar exposure to disruptions in international trade and supply chains, market fluctuations, and resource restrictions induced by the COVID-19 pandemic. Domestically, they all feature highly service-oriented economies, despite the relevant industrial exports. As the service sector is the largest and accounts for up to 50% of the economy in some countries, the limitations on social contact, as well as the domestic and foreign travel restrictions, are expected to have long-term impacts on the region’s overall financial health [24]. This study’s one-year data are limited at best, but some broad trends in the percentage change of real GDP and unemployment show that, even with the inclusion of mandatory preventive measures that directly affect the sustainability of economic activity (as opposed to a limited approach), the lack of mandatory monitoring and prevention seems to levy a similar economic recovery timeline. This is comparable to other countries in the region, while costing a disproportionate number of lives to the pandemic, as in the case of Sweden. These conclusions appear to be further validated by the observed patterns of stock market prices in the Nordic countries (Figure 6). As stock prices are forward-looking, they can reflect at least to some extent the investors’ expectations of the recovery prospects of publicly listed companies. From Figure 6, there is no significant difference in the pattern of stock prices in Sweden from January 2020 to July 2021 relative to the stock price pattern in other Nordic countries in the same timeframe. A Nordic (Denmark, Finland, Norway, and Sweden) labour market study up to week 21 (mid-May) of 2020 showed that the labour markets were severely affected, with the Swedish labour market being impacted by a time lag of 2-3 weeks compared to its neighbours, and the cumulative sum of new unemployment and furlough spells for Sweden remaining significantly lower [16]. However, the cumulative sum of new unemployment and furlough spells of Denmark, Finland, and Norway all showed a decreasing trend when compared to Sweden at week 21 (mid-May) of 2020 and would have likely shown an insignificant result had it continued for the entire time span of our study, until the end of 2020 [16].

Figure 6.  Graph showing comparison of the different stock index’s (January 2020 – July 2021) of each of the Nordic countries. Legend: Yellow: OMXH25 – Helsinki 25 index – Top 25 companies trading in Finland. Green: OMXS30 – Stockholm 30 Index – Top 30 trading in Swede. Red: OMXHN40 – Nordic Top 40 index – Top 40 throughout the Nordic region. Purple: OMXC25 – Copenhagen Top 25 Index – Top 25 trading in Denmark. Cyan: NASDAQ composite – comparison to US market.

An economic study determined the cost of COVID-19 mortality in mid-November 2020 to be nearly US$2 trillion (average global value of statistical life ($1.3 million) multiplied by the global number of COVID-19 deaths of 1 400 000), with US$10 trillion loss in the global GDP [25]. Several pandemic-related factors besides health policy have adversely affected the economy, such as behavioural response and economic shocks (labour supply, demand, financial and uncertainty) and connectedness of economies and communities [26]. With globally interconnected economies, supply chains, imports, and exports, an economy cannot be saved in a pandemic when its international trade partners are suffering due to the implementation of COVID-19 health policy measures [27]. In the absence of a trade-off between public health policy and the economy, delaying pandemic response and mitigation measures is not likely to benefit the economy.

Few studies have investigated the trade-off between the COVID-related health policies and the economy [2528]. Even the studies claiming to report the trade-off are often qualitative or show the impact of higher COVID-19 burden correlating with an economic decline without focusing on health policy measures. Some qualitative evidence is available from the ongoing Evaluation of Science Advice in a Pandemic Emergency (EScAPE) project, a global effort during the COVID-19 pandemic to assess science-based evidence for decision-making, but it does not include hard data to determine trade-offs [29]. A study from the United States (US) showed no trade-off between health policy and economy across the different states, which is consistent with our findings [26]. The United Kingdom had vague, delayed health policies, resulting in a high COVID-19 burden and adverse effects to the economy, relative to neighbouring countries [3032]. On the other hand, Taiwan, South Korea, and Lithuania had strict and effective health policies earlier in the pandemic, which limited the economic impact and led to low COVID-19 deaths [30,33,34]. We do not find a trade-off in health policy measures and the economy in the Nordic region, and the above studies show that this also holds true for other comparable regions ranging from the US and Europe to East Asia.

Limitations of the study include varying epidemiological definitions and methodologies that were reported by countries in the publicly available COVID-19 databases. The results were based on “recorded” COVID-19 cases, and therefore the “true number” is likely to be higher, depending on the definition used in each country to diagnose an active case. The hospitalization and ICU data for Iceland were not available at the time of analysis. Relying on multiple databases to collect the study variables may have led to timeline differences for data reporting. The macroeconomic indicators had fewer data points compared to the epidemiological indicators, leading to analytic differences, especially for the percent change in GDP. Also, factors affecting the economy besides the mitigation measures were not controlled for in this study.


To conclude, this pandemic has demonstrated the variability of COVID-19 mitigation measures across the Nordic countries. Every country has shown a unique reaction, implementing measures based on socioeconomic and geographic factors, epidemiology, health, and politics. Although Sweden had chosen looser COVID-19 health policies to benefit its economy, there is no evidence that this had any short-term economic benefits, while costing disproportionate disease transmission and mortality numbers compared to neighbouring countries.


Michigan State University IRB gave approval for this study.

[1] Funding: This research did not receive any grant from funding agencies in the public, commercial, or not-for-profit sectors.

[2] Authorship Contributions: FBI, RM and NB decided to publish the paper. FBI, RM, NB, AYS, NH and SCB contributed to study design. FBI, RM, AYS, NH, SCB and FSA contributed to data collection. FBI, BT and FSA contributed to statistical analysis. FBI, RM, NB, BT, NH, SCB, BT, WC, AKW, MEA and KJS drafted the manuscript. All authors critically revised the manuscript. All authors had full access to all the data in the study and take final responsibility for the decision to submit for publication. FBI and BT accessed and verified the underlying data.

[3] Competing interests: Irfan FB reports grant from NorthStar Anesthesia, and personal fees for consultancy from Silicon Valley Innovation Center, Infineon Technologies AG, unrelated to this publication. Saleh KJ reports royalties from patents with BBraun; and personal fees for consultancy from Saleh Medical Consulting PLC, Aesculap AG; Medical Director of Legend Health and Sphere Orthopaedics, unrelated to this publication. The authors have completed the ICMJE Unified Competing Interest Form (available upon request from the corresponding author) and declare no further competing interests.


[1] Non-Pharmaceutical Public Health Measures for Mitigating the Risk and Impact of Epidemic and Pandemic Influenza. Geneva: World Health Organization; 2019.

[2] A Segarra-Blasco, M Teruel, and S Cattaruzzo. The economic reaction to non-pharmaceutical interventions during Covid-19. Econ Anal Policy. 2021;72:592-608. DOI: 10.1016/j.eap.2021.10.006. [PMID:34690406]

[3] Coronavirus WHO. (COVID-19) Dashboard. World Health Organization. Published 2021. Available: Accessed: 14 January 2022.

[4] COVID-19. European Centre for Disease Prevention and Control. Published 2021. Available: Accessed: 14 January 2022.

[5] Data on testing for COVID-19 by week and country. European Centre for Disease Prevention and Control. Published 2021. Available: Accessed: 14 January 2022.

[6] Bøtter J. COVID-19 in Scandinavia. Published 2021. Available: Accessed: 14 January 2022.

[7] Variable Dictionary and Disclaimer weekly testing data. European Centre for Disease Prevention and Control. Published 2021. Available: Accessed: 14 January 2022.

[8] T Hale, N Angrist, R Goldszmidt, B Kira, A Petherick, and T Phillips. A global panel database of pandemic policies (Oxford COVID-19 Government Response Tracker). Nat Hum Behav. 2021;5:529-38. DOI: 10.1038/s41562-021-01079-8. [PMID:33686204]

[9] Ritchie H, Ortiz-Ospina E, Beltekian D. Coronavirus Pandemic (COVID-19). OurWorldInData. Published 2020. Available: Accessed: 14 January 2022.

[10] COVID-19 Projections. Institute for Health Metrics and Evaluations. Published 2020. Available: Accessed: 14 January 2022.

[11] The Global Economy. Published 2021. Available: Accessed: 14 January 2022.

[12] Organisation for Economic Co-Operation and Development. Published 2021. Available: Accessed: 14 January 2022.

[13] HJ Kim, MP Fay, EJ Feuer, and DN Midthune. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19:335-51. DOI: 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z. [PMID:10649300]

[14] M Claeson and S Hanson. COVID-19 and the Swedish enigma. Lancet. 2021;397:259-61. DOI: 10.1016/S0140-6736(20)32750-1. [PMID:33357494]

[15] N Thualagant, N Simonsen, and A Sarvimäki. Nordic responses to covid-19 from a health promotion perspective. Health Promot Int. 2022;daac015. DOI: 10.1093/heapro/daac015. [PMID:35212362]

[16] S Juranek, J Paetzold, H Winner, and F Zoutman. Labor market effects of COVID-19 in Sweden and its neighbors: Evidence from administrative data. Kyklos Online. 2021;74:512-26. DOI: 10.1111/kykl.12282. [PMID:34908590]

[17] MS Chew, S Kattainen, N Haase, EA Buanes, LB Kristinsdottir, and K Hofsø. A descriptive study of the surge response and outcomes of ICU patients with COVID-19 during first wave in Nordic countries. Acta Anaesthesiol Scand. 2022;66:56-64. DOI: 10.1111/aas.13983. [PMID:34570897]

[18] DF Gudbjartsson, A Helgason, H Jonsson, OT Magnusson, P Melsted, and GL Norddahl. Spread of SARS-CoV-2 in the Icelandic Population. N Engl J Med. 2020;382:2302-15. DOI: 10.1056/NEJMoa2006100. [PMID:32289214]

[19] D Olagnier and TH Mogensen. The Covid-19 pandemic in Denmark: Big lessons from a small country. Cytokine Growth Factor Rev. 2020;53:10-2. DOI: 10.1016/j.cytogfr.2020.05.005. [PMID:32405247]

[20] EA Yarmol-Matusiak, LE Cipriano, and S Stranges. A comparison of COVID-19 epidemiological indicators in Sweden, Norway, Denmark, and Finland. Scand J Public Health. 2021;49:69-78. DOI: 10.1177/1403494820980264. [PMID:33413051]

[21] C Cot, G Cacciapaglia, and F Sannino. Mining Google and Apple mobility data: temporal anatomy for COVID-19 social distancing. Sci Rep. 2021;11:4150 DOI: 10.1038/s41598-021-83441-4. [PMID:33602967]

[22] J Oh, HY Lee, QL Khuong, JF Markuns, C Bullen, and OEA Barrios. Mobility restrictions were associated with reductions in COVID-19 incidence early in the pandemic: evidence from a real-time evaluation in 34 countries. Sci Rep. 2021;11:13717 DOI: 10.1038/s41598-021-92766-z. [PMID:34215764]

[23] Fellman S. Economic development in the Nordic countries. Published 2019. Available: Accessed: 14 January 2022.

[24] Nordic Statistics database. Nordic Co-operation. Published 2021. Available: Accessed: 14 January 2022.

[25] S Kaplan, J Lefler, and D Zilberman. The political economy of COVID-19. Appl Econ Perspect Policy. Appl Econ Perspect Policy. 2022;44:477-88. DOI: 10.1002/aepp.13164

[26] Lin Z, Meissner C. Health vs. Wealth? Public Health Policies and the Economy during COVID-19. Cambridge; 2020.

[27] Baker S, Farrokhnia R, Meyer S, Pagel M, Yannelis C. How Does Household Spending Respond to an Epidemic? Consumption During the 2020 COVID-19 Pandemic. Cambridge, MA: National Bureau of Economic Research; 2020.

[28] R Dhar, B Jee, and S Karmakar. Balancing Healthcare and Economy Amidst the COVID-19 Pandemic: An Indian Experience. Risk Manag Healthc Policy. 2021;14:827-33. DOI: 10.2147/RMHP.S291084. [PMID:33664604]

[29] EScAPE: Evaluation of Science Advice in a Pandemic Emergency. Published 2022. Available: Accessed: 23 March 2022.

[30] Hasell J. Which countries have protected both health and the economy in the pandemic? Our World in Data. Published September 1, 2020. Available: Accessed: 14 January 2022.

[31] DJ Hunter. Covid-19 and the Stiff Upper Lip – The Pandemic Response in the United Kingdom. N Engl J Med. 2020;382:e31. DOI: 10.1056/NEJMp2005755. [PMID:32197002]

[32] S Allaham, IC Demel, I Nur, FN Abu Salim, and L Manikam. The Impact of United Kingdom and Malaysia’s Inherent Health Systems on Their COVID-19 Responses: A Comparison of Containment Strategies. World Med Health Policy. 2021;10:DOI: 10.1002/wmh3.412. [PMID:34226852]

[33] J Kim, J Moon, TY Jung, W Kim, and HC Yoo. Why Have the Republic of Korea, Taiwan, and Singapore Coped Well with COVID-19 and What Are the Lessons Learned from Their Experiences? Yonsei Med J. 2022;63:296-303. DOI: 10.3349/ymj.2022.63.3.296. [PMID:35184433]

[34] Lithuania: COVID-19 crisis reinforces the need for reforms to drive growth and reduce inequality. Organisation for Economic Co-Operation and Development. Published November 2020. Available: Accessed: 26 March 2022.

Correspondence to:
Furqan B. Irfan, MBBS, PhD, Assistant Professor, Director Research Development
Department of Neurology and Ophthalmology, College of Osteopathic Medicine
Institute of Global Health, Michigan State University
Room 325A, West Fee Hall, 909 Wilson Road
East Lansing
United States 48824
[email protected]